Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.22.1
Stockholders' Equity (Tables)
 12 Months Ended
Jan. 31, 2022
Equity [Abstract]  
Fair Value of Stock Options Granted

The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the fair value of stock options granted:

 

 

 

 

 

For the Fiscal Years Ended January 31,

 

 

 

 

 

2022

 

 

2021

 

Risk-free interest rate

 

 

 

 

0.9

%

 

 

0.3

%

Expected volatility

 

 

 

 

55.8

%

 

 

62.1

%

Expected dividend yield

 

 

 

 

0.0

%

 

 

0.0

%

Expected term (in years)

 

 

 

 

6.4

 

 

 

5.5

 
Stock Option Activity

The following table summarizes the Company’s stock option activity:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Outstanding as of January 31, 2021

 

 

1,672,546

 

 

$

2.00

 

 

 

5.64

 

 

$

—

 

Granted

 

 

1,195,000

 

 

 

1.24

 

 

 

 

 

 

 

 

 

Exercised

 

 

(112,205

)

 

 

1.43

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(1,492,001

)

 

 

1.91

 

 

 

 

 

 

 

 

 

Outstanding as of January 31, 2022

 

 

1,263,340

 

 

$

1.40

 

 

 

8.67

 

 

$

83,300

 

Vested and expected to vest as of January 31, 2022

 

 

1,152,689

 

 

$

1.41

 

 

 

8.63

 

 

$

83,300

 

Options exercisable as of January 31, 2022

 

 

356,677

 

 

$

1.70

 

 

 

7.62

 

 

$

—

 
Summary of Stock Unit Activity

The following table summarizes the Company’s stock unit activity:

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

Grant-Date

 

 

 

Number of Shares

 

 

Fair Value

 

Unvested balance as of January 31, 2021

 

 

1,171,869

 

 

$

1.87

 

Granted

 

 

1,836,004

 

 

 

1.12

 

Vested

 

 

(1,100,691

)

 

 

1.78

 

Forfeited

 

 

(176,634

)

 

 

1.39

 

Unvested balance as of January 31, 2022

 

 

1,730,548

 

 

$

1.18

 
Summary of Stock Based Compensation Expense Recognized

The Company recognized stock-based compensation expense within the consolidated statements of operations and comprehensive loss as follows:

 

 

 

For the Fiscal Years

Ended January 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cost of revenue

 

$

35

 

 

$

(8

)

Research and development

 

 

(77

)

 

 

292

 

Sales and marketing

 

 

114

 

 

 

96

 

General and administrative

 

 

1,618

 

 

 

867

 

 

 

$

1,690

 

 

$

1,247